U492218.pdf (26.83 MB)
Download file

Human toll - like receptor 9 (hTLR9) expression and function in haematological and non-haematological malignancies

Download (26.83 MB)
posted on 15.12.2014, 10:39 by Areej Mashhour Tawfiq Assaf
This thesis addresses the expression and function of human TLR9 in haematological and non-haematological tumour cells. I have shown that most B linage tumour cell lines expressed TLR9, with the exception of myeloma cell lines U266, Karpas 707H and the EBV-lymphoblastoid HMy2 cell line, whereas all non-haematological cell lines tested were negative or very weakly positive. TLR9 positive B-cells/B-cell lines, responded to CpG-ODN activation by activating intracellular signalling pathways, cytokine release, surface marker upregulation and cellular proliferation, whereas TLR9 negative cells did not.;Data on the ability of pre-treatment with low doses of CpG-ODN to induce a refractory state (tolerance) on Burkitt's lymphoma BJAB cells indicates that low doses of CpG-ODN tolerised NF-kappaB activation and, to some extent, cellular proliferation and surface marker upregulation. Moreover, reactivating NF-kappaB on BJAB cells after being tolerised with low dose of CpG-ODN is time dependent with the tolerising effect lasting up to two weeks after a single dose of CpG-ODN.;Finally, inhibiting the signalling pathways (ERK, p38MAPK, PI3K/AKTand NF-kappaB) with selective inhibitors U0126, SB203580, LY294002 and Curcumin respectively, has shown different effects on basal and CpG-ODN activated surface marker expression, cellular proliferation and cytokine release. Furthermore, different signalling pathways mediate different functional effects of CpG-ODN/TLR9 activation, and suggest that ERK and p38 MAPK pathways are involved in CpG-ODN mediated NF-kappaB activation. This work should shed a new light on the mechanisms of action of CpG activation on TLR5 signalling in immune and non-immune cells and on its immunotherapeutic use in the treatment of cancer.


Date of award


Author affiliation

Infection immunity and inflammation

Awarding institution

University of Leicester

Qualification level


Qualification name




Usage metrics